{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/dyspepsia-unidentified-cause/","result":{"data":{"firstChapter":{"id":"9fdd530d-f12b-5642-954b-6284524a3fdb","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 1dc8d9be-e622-4655-9556-fc3c8767db74 --><h1>Dyspepsia - unidentified cause: Summary</h1><!-- end field 1dc8d9be-e622-4655-9556-fc3c8767db74 -->","htmlStringContent":"<!-- begin item b08ab4ea-3600-4042-b88f-7047a3b2dfae --><!-- begin field a3ef220e-8e86-4ecc-8445-5b3d90da6f35 --><ul><li>The term 'dyspepsia' is used to describe a complex of upper gastrointestinal tract symptoms which are typically present for four or more weeks, including upper abdominal pain or discomfort, heartburn, acid reflux, nausea and/or vomiting.<ul><li>Reported symptoms are a poor predictor of significant disease or underlying pathology.</li><li>'Uninvestigated' dyspepsia describes symptoms in people who have not had an endoscopy.</li></ul></li><li>The most common causes of dyspepsia include:<ul><li>Gastro-oesophageal reflux disease (GORD).</li><li>Peptic ulcer disease (gastric or duodenal ulcers).</li><li>Functional dyspepsia (non-ulcer dyspepsia).</li></ul></li><li>Dyspepsia symptoms are estimated to occur in about 40% of the population each year.</li><li>Assessment of a person with unexplained dyspepsia should include:<ul><li>Asking about any alarm symptoms that may suggest a complication or other serious underlying pathology.</li><li>Asking about lifestyle factors and associated stress, anxiety, or depression.</li><li>Reviewing the person's medication, including drugs that can cause or exacerbate dyspepsia, such as nonsteroidal anti-inflammatory drugs (NSAIDs).</li><li>Considering an alternative diagnosis.</li><li>Considering arranging a full blood count, to check for anaemia and/or a raised platelet count, which may suggest underlying malignancy.</li></ul></li><li>Initial management of a person with unexplained dyspepsia should include:<ul><li>Offering advice on lifestyle modification.</li><li>Managing any associated stress, anxiety, or depression.</li><li>Reducing or stopping any drugs that may cause or exacerbate dyspepsia, if possible and appropriate.</li></ul></li><li>If symptoms persist, a full-dose proton pump inhibitor (PPI) should be prescribed for 1 month <em>or </em>testing for <em>Helicobacter pylori</em> infection should be arranged, if the person's status is not known or uncertain.<ul><li>Ideally, a carbon-13 urea breath test or stool antigen test should be used — ensuring the person has not taken a PPI in the past 2 weeks, or antibiotics in the past 4 weeks.</li><li>If the person tests positive for <em>H. pylori </em>infection, first-line eradication therapy should be offered.</li><li>If symptoms persist or recur, the alternative strategy should be offered.</li></ul></li><li>For people with persistent or recurrent symptoms following initial management:<ul><li>Alternative acid suppression therapy with a histamine (H<sub>2</sub>)-receptor antagonist (H<sub>2</sub>RA) may be considered.</li><li>Long-term acid suppression therapy can be considered if symptoms have previously responded.</li></ul></li><li><em>H. pylori</em> re-testing should not be offered routinely but may be considered in some circumstances.<ul><li>If the test is positive, second-line eradication therapy should be offered.</li></ul></li><li>People on long-term treatment for uninvestigated dyspepsia should be:<ul><li>Offered an annual review.</li><li>Encouraged to step down or stop treatment, if possible and appropriate.</li></ul></li><li>Referral for endoscopy or to a gastroenterologist should be considered, depending on clinical judgement, if:<ul><li>There are refractory or recurrent symptoms despite optimal management in primary care.</li><li>Treatment with a second-line <em>H. pylori</em> eradication regimen has been unsuccessful.</li><li>There are limited antibiotic options for <em>H. pylori</em> eradication therapy.</li></ul></li></ul><!-- end field a3ef220e-8e86-4ecc-8445-5b3d90da6f35 --><!-- end item b08ab4ea-3600-4042-b88f-7047a3b2dfae -->","topic":{"id":"f89632d0-8e52-59da-bd63-555a73aa134f","topicId":"ac596995-c452-4bf5-81bf-0aea66eca309","topicName":"Dyspepsia - unidentified cause","slug":"dyspepsia-unidentified-cause","aliases":[],"chapters":[{"id":"9fdd530d-f12b-5642-954b-6284524a3fdb","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"4ac2b712-5571-56ca-9ac4-25c9e354a821","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"16fcbe75-c057-5b25-8039-9145eb897f12","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"be6e1eb9-7eb4-54b8-980d-7a18a90127c3","slug":"changes","fullItemName":"Changes"},{"id":"8eb7dbc2-40da-5433-b290-44902a364d61","slug":"update","fullItemName":"Update"}]},{"id":"a44ffd66-34ee-565e-8b89-d09f62dd9656","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"ad917944-2a8c-561c-ba7d-5e5c7ea860e4","slug":"goals","fullItemName":"Goals"},{"id":"cbb4bad0-1dbe-5c62-9adc-bb1a65fe6381","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"54d592f8-f244-5cc8-aed5-81cb136af042","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4ca8a0b2-46c5-52c2-a05d-1ae84806cefd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5e33c66-dee5-57d8-9eff-828ad855e204","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"eff9b41a-cac2-5b9a-8614-2486d8206ffd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4dfc51d9-1416-5432-bc80-019f5708238c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"ec8766af-6b0a-5a4d-8897-2e3ba2af658d","slug":"definition","fullItemName":"Definition"},{"id":"e1cbef45-8ac7-5376-a1d2-c5d0a2cc924b","slug":"causes","fullItemName":"Causes"},{"id":"c7487dda-a4e1-5d9e-bc96-e583302af12c","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"0eb82dd3-e433-5b8e-a8d9-46987aab8940","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d2acef31-cf6d-5e3e-b2e0-99bc02684183","slug":"assessment","fullItemName":"Assessment"},{"id":"86ebd63c-3596-5ac0-9cd3-4a312bb2d7e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f244ecd9-294a-5fa3-9b22-a2e8f2ae408c","slug":"management","fullItemName":"Management","subChapters":[{"id":"bafb1a12-7cf3-5c6c-921a-03d86efd995d","slug":"dyspepsia-unidentified-cause","fullItemName":"Scenario: Dyspepsia - unidentified cause"}]},{"id":"b50160d9-c6d3-5b75-a3a3-9a743c039fb4","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"2978bf31-384a-5964-bba7-5ca72e2a700a","slug":"proton-pump-inhibitors-ppis","fullItemName":"Proton pump inhibitors (PPIs)"},{"id":"a51b3918-0bed-5c45-887b-a5d3e5fd3031","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"},{"id":"8579e41d-876a-5f82-9cb8-04675dce1bb3","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"d41b619e-ef9e-59b6-876b-0b3d52f0884a","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"9ea259a4-6c7f-524f-8866-6164a9696c25","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"640d4b46-3f9c-5cef-aeda-9a374a03fae8","slug":"tetracycline","fullItemName":"Tetracycline"},{"id":"fe5b2b68-8d84-5867-bc39-c63cbcd815f8","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"0857fa25-e261-5ecd-b851-fbe52518072d","slug":"bismuth","fullItemName":"Bismuth"}]},{"id":"210b1a7b-a0e0-558a-acbe-539f538e840d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"0e0cffca-8140-5660-bd87-d4288485522f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"4726f06d-25b6-56d1-83c0-3d729c2bb571","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"301b4d9b-8d13-5cc1-8e9a-f8f68c4fa019","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5e963a22-e16a-5e4a-b7a9-072decaccaa1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d1d047d4-3011-5ca0-955c-b366ab2a9fb4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cd5de0cc-ba55-5ad9-b09b-3025cc68334c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cc0ebb19-4869-5b31-8bcf-f0b6e5af54db","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"f89632d0-8e52-59da-bd63-555a73aa134f","topicId":"ac596995-c452-4bf5-81bf-0aea66eca309","topicName":"Dyspepsia - unidentified cause","slug":"dyspepsia-unidentified-cause","aliases":[],"topicSummary":"The term 'dyspepsia' is used to describe a complex of upper gastrointestinal tract symptoms","lastRevised":"Last revised in October 2018","nextPlannedReviewBy":"2022-10-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-09","nextPlannedReviewByDisplay":"September 2022","specialities":[{"id":"e4fd15e3-ef70-523f-843c-5270742f518d","name":"Gastrointestinal","slug":"gastrointestinal"}],"chapters":[{"id":"9fdd530d-f12b-5642-954b-6284524a3fdb","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"4ac2b712-5571-56ca-9ac4-25c9e354a821","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"16fcbe75-c057-5b25-8039-9145eb897f12","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"be6e1eb9-7eb4-54b8-980d-7a18a90127c3","slug":"changes","fullItemName":"Changes"},{"id":"8eb7dbc2-40da-5433-b290-44902a364d61","slug":"update","fullItemName":"Update"}]},{"id":"a44ffd66-34ee-565e-8b89-d09f62dd9656","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"ad917944-2a8c-561c-ba7d-5e5c7ea860e4","slug":"goals","fullItemName":"Goals"},{"id":"cbb4bad0-1dbe-5c62-9adc-bb1a65fe6381","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"54d592f8-f244-5cc8-aed5-81cb136af042","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4ca8a0b2-46c5-52c2-a05d-1ae84806cefd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5e33c66-dee5-57d8-9eff-828ad855e204","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"eff9b41a-cac2-5b9a-8614-2486d8206ffd","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4dfc51d9-1416-5432-bc80-019f5708238c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"ec8766af-6b0a-5a4d-8897-2e3ba2af658d","slug":"definition","fullItemName":"Definition"},{"id":"e1cbef45-8ac7-5376-a1d2-c5d0a2cc924b","slug":"causes","fullItemName":"Causes"},{"id":"c7487dda-a4e1-5d9e-bc96-e583302af12c","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"0eb82dd3-e433-5b8e-a8d9-46987aab8940","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"d2acef31-cf6d-5e3e-b2e0-99bc02684183","slug":"assessment","fullItemName":"Assessment"},{"id":"86ebd63c-3596-5ac0-9cd3-4a312bb2d7e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f244ecd9-294a-5fa3-9b22-a2e8f2ae408c","slug":"management","fullItemName":"Management","subChapters":[{"id":"bafb1a12-7cf3-5c6c-921a-03d86efd995d","slug":"dyspepsia-unidentified-cause","fullItemName":"Scenario: Dyspepsia - unidentified cause"}]},{"id":"b50160d9-c6d3-5b75-a3a3-9a743c039fb4","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"2978bf31-384a-5964-bba7-5ca72e2a700a","slug":"proton-pump-inhibitors-ppis","fullItemName":"Proton pump inhibitors (PPIs)"},{"id":"a51b3918-0bed-5c45-887b-a5d3e5fd3031","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"},{"id":"8579e41d-876a-5f82-9cb8-04675dce1bb3","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"d41b619e-ef9e-59b6-876b-0b3d52f0884a","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"9ea259a4-6c7f-524f-8866-6164a9696c25","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"640d4b46-3f9c-5cef-aeda-9a374a03fae8","slug":"tetracycline","fullItemName":"Tetracycline"},{"id":"fe5b2b68-8d84-5867-bc39-c63cbcd815f8","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"0857fa25-e261-5ecd-b851-fbe52518072d","slug":"bismuth","fullItemName":"Bismuth"}]},{"id":"210b1a7b-a0e0-558a-acbe-539f538e840d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"0e0cffca-8140-5660-bd87-d4288485522f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"4726f06d-25b6-56d1-83c0-3d729c2bb571","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"301b4d9b-8d13-5cc1-8e9a-f8f68c4fa019","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5e963a22-e16a-5e4a-b7a9-072decaccaa1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d1d047d4-3011-5ca0-955c-b366ab2a9fb4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cd5de0cc-ba55-5ad9-b09b-3025cc68334c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"cc0ebb19-4869-5b31-8bcf-f0b6e5af54db","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"f89632d0-8e52-59da-bd63-555a73aa134f"}},"staticQueryHashes":["3666801979"]}